OK Biotech Co., Ltd.

TWSE:4155 Stock Report

Market Cap: NT$3.3b

OK Biotech Balance Sheet Health

Financial Health criteria checks 5/6

OK Biotech has a total shareholder equity of NT$2.5B and total debt of NT$498.2M, which brings its debt-to-equity ratio to 20.3%. Its total assets and total liabilities are NT$3.4B and NT$973.4M respectively. OK Biotech's EBIT is NT$9.2M making its interest coverage ratio -9.7. It has cash and short-term investments of NT$192.8M.

Key information

20.3%

Debt to equity ratio

NT$498.25m

Debt

Interest coverage ratio-9.7x
CashNT$192.84m
EquityNT$2.46b
Total liabilitiesNT$973.44m
Total assetsNT$3.43b

Recent financial health updates

OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Mar 17
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Dec 08
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Recent updates

OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

Aug 20
OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Apr 26
OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

Apr 04
Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Mar 17
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Mar 01
Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

Feb 15
Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

A Look At OK Biotech's (TPE:4155) Share Price Returns

Jan 31
A Look At OK Biotech's (TPE:4155) Share Price Returns

We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Jan 17
We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Jan 03
Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Dec 21
Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Dec 08
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Nov 23
Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Financial Position Analysis

Short Term Liabilities: 4155's short term assets (NT$1.3B) exceed its short term liabilities (NT$707.7M).

Long Term Liabilities: 4155's short term assets (NT$1.3B) exceed its long term liabilities (NT$265.7M).

Debt to Equity History and Analysis

Debt Level: 4155's net debt to equity ratio (12.4%) is considered satisfactory.

Reducing Debt: 4155's debt to equity ratio has reduced from 42.1% to 20.3% over the past 5 years.

Debt Coverage: 4155's debt is not well covered by operating cash flow (14.6%).

Interest Coverage: 4155 earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y